chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In April of 2021 (3 months after second COVID shot), I developed right wrist pain. I have not had this before, however, there is a family history of joint issues and working from home increased handheld device use in my right hand. The pain and limitations due to this pain progressed until I eventually sought treatment in July of 2021. It was identified to be De Quervain's tenosynovitis. I received a cortisone injection in early July and my symptoms have mostly resolved for the time being.
01/31/2010, all day - Malaise, myalgia 02/01/2010, all day, stayed home from work - Malaise, myalgia, severe headache, nausea, dizziness 02/02/2010, all day, stayed home from work - Severe nausea, malaise, myalgia, dizziness
Pt recv vax in 11/98; 4 - 5 day post vax pt exp itching & pimples filled w/ water at vax site x 10 day
I had a mild rash after my 1st shot... really didn't remember till the dayn after my 2sd shot... i woke up with red itchy arms and legs. I had small welts around my waist and inner thighs. I showed my wife , she said use some anti itch  cream in the bathroom.I did and it got better... went back to sleep. the next night i woke anain to really red and pissed off knees with welts all over my legs.. Treated again  with cream. the next night...4-12-2021 it only started on both feet..kinda itchy with mild pain..no cream.. all good sofar..
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Jan2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Prediabetes" (unspecified if ongoing); "allergies Kiwi persimmons" (unspecified if ongoing); "allergies eggplant" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of covid-19 with NyQuil DayQuil Advil.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I have no idea what vaccine they gave me. I just went and they give me a shot. I will be calling back with missing information.  muscle and joint pain lower sense of touch or feeling allergic reactions to hives started getting itchy like poison ivy I went to the doctor
pt recv vax 24APR96 & devel an inj site rxn characterized by redness & itching;additional info recv 21JUN96 pt recovered;
Psoriasis flare-up; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis flare-up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 15-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PSORIASIS (Psoriasis flare-up). At the time of the report, PSORIASIS (Psoriasis flare-up) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were provided by the reporter.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's causality for the event(s) of PLAQUE PSORIASIS FLARE UP was not provided.  No treatment medications were provided by the reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked in.  Reporter did not allow further contact
fever; chills; headache; fatigue; This is a spontaneous report from Pfizer via a contactable consumer (mother). A 92-year old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (at the age of 92-years-old), via an unspecified route of administration on 21Jan2021 as a single dose for covid-19 immunization.  The patient has no medical history and Is not taking any concomitant medications. On 26Jan2021, she experienced fever, chills, headache, and fatigue. The clinical outcome of the events fever, chills, headache, fatigue was not recovered.  Information on Lot/Batch has been requested.
Lip twitching, head twitches and going cross eyed September 2016, lasting approximately a couple months.
Got the shot and has the shingles/Suspected vaccination failure; She has the shingles just terrible; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 28-Mar-2022 Reporter's Comments:  This case was received from patient's cousin via interactive digital media. The patient got Shingle vaccine and still had shingles and it was just terrible. Additional Supportive Information: This case described the occurrence of suspected vaccination failure. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Stomach ache, headache, diarrhea until about noon on 11/12/10. Had no pain in arm at all.
Left arm and shoulder pain and weakness, decending to torso, hip and left leg.  Muscle aches and fatigue x 3 days.
27Sep90 pt vax w/ 2nd hepta B; exp elevated liver enzymes.  Pt is undergoing tests to ascertain cause of elevation.
PRESENTS WITH C/O THROAT "TIGHTENING" FEELING FLUSHED/ ANXIOUS, DIFFICULTY BREATHING WHICH STARTED SHORTLY AFTER RECEIVING COVID VACCINATION. HAS H/O ASTHMA. USED INHALER PTA. THIS IS SECOND INJECTION. STATES HE HAD SIMILAR REACTION WHICH RESOLVED SPONTANEOUSLY WITH FIRST INJECTION.  Pulse Ox 100%, Pulse 100 bpm, respiratory rate 20 bpm, BP 173/96
Information has been received from a nurse referring to 4 years old patient of unknown gender. Information about concomitant medications, pertinent medical history and drug/allergies reactions was not provided. On 18-JAN-2019, the patient was inadvertently administered a dose of PNEUMOVAX 23 (lot # R022249 and expiration date 16-APR-2020; frequency and route were not provided) for prophylaxis instead of PREVNAR 13 (wrong product administered). No adverse effects were reported.
Caller reported his own AE; Soreness in his arm; Blood in his urine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Caller reported his own AE), PAIN IN EXTREMITY (Soreness in his arm) and BLOOD URINE PRESENT (Blood in his urine) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007N20A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness in his arm) and BLOOD URINE PRESENT (Blood in his urine). On an unknown date, the patient experienced VACCINATION COMPLICATION (Caller reported his own AE). At the time of the report, VACCINATION COMPLICATION (Caller reported his own AE), PAIN IN EXTREMITY (Soreness in his arm) and BLOOD URINE PRESENT (Blood in his urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported. No treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Sep-2021: Follow up contain significant information: Events - Blood in urine a nd soreness in arm were added. Dose 2 details added. Dose 1 details updated.
Site: Pain at Injection Site-Severe, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: patient came in to get booster and said she has been having pain, numbness and tingling in her left arm since she got the 2nd covid vaccine and through all vaccines since. she wanted to get the booster to prevent covid but mentioned that it was sore and achey the days following the vaccine and it has slowly gotten worse and it affects her daily life. She does not have a primary care doctor, I encouraged her to go to urgent care.
Within a few hours, shivering, stomach pain, headache and fever set in.  Fever and aching throughout night.  We called the doctor in the morning and was told it can happen after flu shot. 2 Tylenol every 4 hours.  Fever left around 10 hours after shot.  Fatigue, loss of appeite, headache and severe body aches through second night.  Next morning headache and little body aches remain.  This  is the time of reporting.
SORE ARM LASTING 4 DAYS; SWEATING, FEVERISH FOR ONE NIGHT.
Restong heart rate jumped to 100bpm when normal resting rate 8s 58 to 60bpm. Normal heart rate returned after 4 minutes.  Jaw line, nose, back of the head and upper back went numb for 6+ hours after 1st vaccine. Second vaccine administered  on March 18th at 1130.  Jaw line and nose went numb for entire day. Woke up next morning and it was back to normal. A cough and chest pain started March 20th and it still is present today(April 9th) Primary doctor is useless and can't help.
1 of 2 pts immunized from same vial who developed inject site react; pt immunized 1SEP92 & devel induration of 3 cm; no lymph node involvement;
Febrile seizure (fever 103) for 5 minutes the morning after her 6 month H1N1 and seasonal flu vaccines. Went to ED. Did not need antiepileptic med.
Out of the blue, I got nausea and diarrhea the most severe in my whole life.  I was vomiting and periodically having diarrhea for four hours.  I felt faint.  Had a hard time standing.  I have never had anything like that in my whole life and I have had food poisoning in the past.  This was worse, much worse.  Afterwards, for days, I was weak and now three days later still have some nausea although I am not throwing up.  I do have loose bowels though.
10 days past reaction: 2/15/19 noticed rash across abdomen. 2/16/19 rash from chest down to feet with swollen lymph nodes back of head/neck area. Joint pain. Only treatment OTC anti-inflammatory medication.
Conjunctivitis symptoms in one eye that went away after 10 hours (crusted discharge on eye line).
Given outside of recommendations.  Follow up with Mother on 12/31/21 - Mother stated was having vomiting and diarrhea but she felt it was not related to the vaccine that was given.
Had Typhoid shot 4 days ago. Post vax, he noticed increased erythema and pain (some yesterday) on site of injection. Got the shot in triceps area. Had 1 lesion on right triceps arm and large patch of erythema with fuzzy border and tenderness plus axillary nodes. Dx'd with acute right upper arm cellulitis. Treated with Augmentin and Motrin. Return to clinic or ER if worsens. Use cool compresses.
chills, nausea, fever, fatigue, food aversion, headache, muscle ache, Injection site pain
Nose bleed at about 25 minutes after second Covid Vaccine.   That is unusual for me  to have a nose bleed.  It took about 30 minutes to stop flow.  Stopped by Clinic and saw NP.  There was no pain, just sudden blood flow.
redness, swelling, and rash that lasted about 7 days.  Redness persists.
Woke up Tuesday morning and body started breaking out into hives and rash, wouldn?t go away with Benadryl after 3 days of having it. Eventually talked to a Telehealth doctor who prescribed prednisone and started that but the following morning it had gotten worse, I went to my local urgent care and was provided a steroid shot and an additional allergy medication at the time. After about 10 days of treatment I was still having small rashes soI have been on OTC allergy medication since the end of January just to be safe.  To this day we don?t 100% know if it was the vaccine or the Bupropion I was one at the time, was advised to stop my medication immediately and never take it again and to not get the second dose of the Covid 19 Moderna Vaccine.
immunization (site on the right upper arm) on 1/10/21 with increased right arm pain at rest and movement, then flu like symptoms 1/11-14/21: aches, fatigue, malaise, head ache; on 1/12/21 in the afternoon I noticed right axilla pain in axilla, same level at the upper back/ribcage under the shoulder blade and corresponding pectoralis muscles and swell in axilla and upper pectoralis muscles, I  could also palpitate multiple firm and tender lymph nodes at the right axilla.
This case was reported by a physician to a sales representative and described the occurrence of injection site redness in a child of unspecified gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. The physician reported several subjects experienced an injection site reaction following receipt of Infanrix, however, a specified number of subjects was not reported. On unspecified date on or before 25 April 2006, the subject received a dose of Infanrix at an unspecified site of injection (dose number not reported; lot AC14A006AA). At an unspecified time after vaccination with Infanrix, on an date on or before 25 April 2006, the subject experienced injection site redness and swelling injection site. The outcome of the events was not reported.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with an improperly stored doses of M-M-R II lot # M45101 an expiration date: 10-NOV-2018. The M-M-R II was reconstituted with sterile diluent (manufacturer unknown) which did not undergo a temperature excursion. No adverse effects were reported. The digital data logger was involved in recording the temperature excursion. This is one of four reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA010646: US-009507513-1708USA010647: US-009507513-1708USA008059.
This spontaneous report as received from a nurse practitioner, via a company representative, refers to a patient of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX, (lot number and expiry date not provided) intramuscular. On an unknown date, the patient had received a dose of ZOSTZVAX administered intramuscularly rather than subcutaneously and that the patient had developed an injection site reaction, recently (date unspecified). The dose of ZOSTAVAX was not administered by the nurse practitioner, but at an unspecified Walgreens Pharmacy. The outcome of injections site reaction and a dose of ZOSTAVAX administered intramuscularly rather than subcutaneously was unknown. The reporter did not assess the relatedness between the injections site reaction and ZOSTAVAX. Additional information has been requested.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unknown age and gender. No concurrent conditions, medical history and drug allergies were reported. On an unknown date, the patients were vaccinated with improperly stored doses of (Merck) VARIVAX (Lot number L003775 and expiry date 04-FEB-2017) (dosing regimen and route unknown). No concomitant medications were reported. No adverse effects were reported. Lot number L003775 with expiry date 04-FEB-2017 has been verified to be a valid lot number for (Merck) VARIVAX. Follow-up information has been received on 03-AUG-2015. Telephone call was made to the medical assistant. A voicemail message was left requesting she return the phone call. Additionally, a request was made for patient identifiers, lot number and expiration date and date of vaccination. All telephone attempts to obtain follow up information have been unsuccessful. Follow-up information has been received on 05-AUG-2015, a call was received from the certified medical assistant who reported that she would have to research the request made for patient identifiers, lot number, expiration date and dates of vaccination. The company fax number was reviewed with the reporter, if information becomes available. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015, regarding a 13-month-old (reported as 1-year-old) patient of unknown gender. On 01-OCT-2015, the patient was vaccinated with an improperly stored dose of (Merck) VARIVAX lot # L003775. The vaccine was purchased with public funds as a part of a program. This is one of several reports received from the same source. Additional information has been requested. Patient's details, event information and narrative were updated.
4-2021 Rash on chest, bil UE, bil lower extremities, pruritic  better on May 3, all rashes resolved. Treatment received Medrol Dose pack, Zyrtec Benadryl PRN. Treatment completed
LEFT SIDED THROAT PAIN; LEFT EAR PAIN; PAIN UNDER LEFT EYE; LEFT SIDED HEADACHE; TIRED; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included osteoporosis, seasonal allergy, alcohol user, and non-smoker, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting and had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, and batch number: 1805031 expiry: 26-MAY-2021) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On FEB-2021, Laboratory data included: Endocrine function test (NR: not provided) within normal limits. On MAR-2021, treatment medications included: naproxen. On 07-MAR-2021, the subject experienced left sided throat pain. On 07-MAR-2021, the subject experienced left ear pain. On 07-MAR-2021, the subject experienced pain under left eye. On 07-MAR-2021, the subject experienced left sided headache. On 07-MAR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left sided headache, and tired, and the outcome of left sided throat pain, left ear pain and pain under left eye was not reported. This report was non-serious.
Patient states that she had a large welt on her arm three to four hours after receiving the flu vaccine.  She stated that it progressed down her arm towards her fingers and then moved to cover her trunk and arms.  She described it as itchy.
Anaphylaxis with hypotension, fever, swelling of arm, leukocytosis
Information has been received from a physician concerning a 57 year old male patient who on Feb 24 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650082/0691P). Subsequently, the same day, the patient developed a fever, redness and swelling at the injection site. It was reported that the patient will be treated with diphenhydramine hydrochloride (Benadryl). The physician reported that the patient is recovering from fever, redness, and swelling at the injection site. There was no product guality complaint involved. Additional information has been requested.
Swelling of lower extremities; Maculopapular rashes all over body esp below waist developed 2 wks p/getting MMR till now; Rx Atarax;
Vaccine administered after temperature excursion; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion). On 02-Apr-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) had resolved. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Treatment information was not provided.
PT FAINTED A FEW MINUTES AFTER THE SHOT, WAS OUT FOR 30 SECONDS AND CAME AROUND IN A COLD SWEAT WHICH LASTED ABOUT 15 MINUTES GAVE ORANGE JUICE AND GRANOLA BAR AND HER COLOR CAME BACK AND SYMPTOMS LESS. PATIENT REFUSED AMBULANCE AND DOCTOR VISIT. SAID THIS HAPPENS EVERY TIME SHE GETS AN IMMUNIZATION
Patient stated  feeling lightheadedness 13 minutes post vacccination, patient verbalize lighteadedness. Vitals signs obtained at 03:28pm B/P: 183/98 HR: 82 bpm SpO2: 100% Temp 97.4 F AT 03:34pm B/P 167/83 HR: 82bpm SpO2: 100%  AT 03:44pm B/P 161/74 HR: 86bpm SpO2: 100% Patient verbalized that she feels better @ 15:50 stood up w/o lightheadedness, picked up by son  at 15:52pm Patiet advised to follow up with PCP prior second dose.
Breakthrough COVID Case. This patient completed series 1/13/21. Positive 7/13/21